DAWNA HAZELWOOD: Open Payments
NPI 1942715909 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 39 payments from 14 companies in 2025. Trend: 2023 $552 · 2024 $451 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 7 | $163 |
| Novo Nordisk Inc | 1 | $122 |
| Novartis Pharmaceuticals Corporation | 3 | $97 |
| AstraZeneca Pharmaceuticals LP | 6 | $97 |
| AtriCure, Inc. | 4 | $93 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $63 |
| ABIOMED | 2 | $58 |
| Alnylam Pharmaceuticals Inc. | 1 | $35 |
| Boston Scientific Corporation | 1 | $34 |
| PFIZER INC. | 1 | $26 |
Products named: Assure WCD, Wegovy, LEQVIO, FARXIGA, SYNERGY ABLATION SYSTEM, LifeVest, ONPATTRO, General - Therapies.
Industry payments across FL — which companies pay providers there.
